Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study

  • End date
    Nov 1, 2024
  • participants needed
  • sponsor
    Erasmus Medical Center
Updated on 2 February 2021
Heidi Ammerlaan, MD PhD
Primary Contact
Catharina Ziekenhuis (7.3 mi away) Contact
+8 other location


This study aims to determine real-life clinical efficacy of virally suppressed patienst switching to DTG/3TC compared to DTG triple drug cART controls


Dolutegravir (DTG) based dual antiretroviral therapy constitutes a paradigm shift from triple drug based therapy. Data outside clinical trials are scarce. This study evaluates the value of DTG/3TC in real life.

Condition HIV, HIV positive, HIV infection, AIDS Vaccines, HIV (Pediatric), HIV Infections, human immunodeficiency virus, hiv disease, HIV Vaccine, hiv vaccines
Treatment Dolutegravir / Lamivudine Pill
Clinical Study IdentifierNCT04707326
SponsorErasmus Medical Center
Last Modified on2 February 2021


Yes No Not Sure

Inclusion Criteria

Plasma HIVRNA <50c/mL on triple drug cART regimen including 2NRTI In care in a
HIV treatment center in the Netherlands Consented to ATHENA participation

Exclusion Criteria

Documented mutations associated with 3TC or DTG resistance of at least low
level Documented inadherence by the treating physician or HepB coinfection
(cases only)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note